STOCK TITAN

Skye Bioscience, Inc. (SKYE) Free Cash Flow by Year

SKYE

Skye Bioscience, Inc. recorded an outflow of $43.1M in free cash flow in fiscal year 2025. This represents a decrease of 60.5% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to an outflow of $38.8M in free cash flow. The table below carries 14 fiscal years, from 2012 to 2025, and the quarters Skye Bioscience, Inc. has filed alongside them.

FY2025 annual
Free Cash Flow -$43.1M
YoY -60.5%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

SKYE Free Cash Flow by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY25DEF 14AFY24DEF 14AFY23DEF 14AFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-K
Free Cash Flow-$38.8M-$43.1M-60.5%-$26.8M-92.2%-$14.0M-9.3%-$12.8M-94.5%-$6.6M-8.3%-$6.1MN/A-$3.9MN/AN/A-$3.7MN/A-$64KN/A

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

SKYE Free Cash Flow by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Free Cash Flow-$7.1M+33.7%-$8.6M+6.9%-$9.8M-18.8%-$13.4M-97.1%-$10.7M-50.8%-$9.2M-95.1%-$8.2M-113.5%-$6.8M-67.1%-$7.1M-257.8%-$4.7M-16.0%-$3.9M+21.1%-$4.1M-96.3%

What free cash flow means

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.

More Skye Bioscience, Inc. financials

Frequently Asked Questions

What was Skye Bioscience, Inc.'s free cash flow in fiscal year 2025?

Skye Bioscience, Inc. recorded an outflow of $43.1M in free cash flow in fiscal year 2025.

How fast is Skye Bioscience, Inc.'s free cash flow growing?

Skye Bioscience, Inc. (SKYE) free cash flow fell by 60.5% year over year, from -$26.8M to -$43.1M in fiscal year 2025.

What is Skye Bioscience, Inc.'s free cash flow over the last twelve months?

Skye Bioscience, Inc. (SKYE) reported an outflow of $38.8M in free cash flow over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Skye Bioscience, Inc. (SKYE) reported -$7.1M in free cash flow in Q2 2026. This represents an increase of 33.7% from the same quarter a year earlier.

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Skye Bioscience, Inc. (SKYE) reported on that line in every period on record.